Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
company
|
| gptkbp:focusesOn |
healthcare
|
| gptkbp:hasAccreditation |
gptkb:Agena_Bioscience
Genelex |
| gptkbp:hasDepartment |
gptkb:NVTA
|
| gptkbp:hasEmployees |
over 500
|
| gptkbp:hasFacility |
2015
|
| gptkbp:hasPart |
research and development
biotechnology clinical guidelines clinical trials community outreach programs customer support services data analytics patient support services patient-centered care software solutions telehealth services bioinformatics clinical services genetic counseling patient education programs pharmacogenomics quality assurance programs laboratory services patient engagement tools collaborations with universities clinical pathways clinical education laboratory information management systems partnerships with healthcare providers clinical integration healthcare_policy_advocacy healthcare_analytics |
| gptkbp:hasResidence |
$100 million
|
| https://www.w3.org/2000/01/rdf-schema#label |
NVTA
|
| gptkbp:isActiveIn |
genomics industry
|
| gptkbp:isHeadquarteredIn |
gptkb:Virginia
|
| gptkbp:isInvolvedIn |
patient safety
regulatory compliance drug development medical research patient care personalized medicine public health initiatives clinical research genetic research clinical decision support healthcare education healthcare_access healthcare_delivery healthcare_technology healthcare_collaboration healthcare_innovation healthcare_transformation healthcare_outcomes_research |
| gptkbp:isKnownFor |
innovative testing solutions
|
| gptkbp:isLedBy |
CEO
|
| gptkbp:isPartOf |
gptkb:NASDAQ
|
| gptkbp:isRecognizedBy |
gptkb:FDA
|
| gptkbp:provides |
genetic testing
|